Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy
Robert J. de Vos; Adam Weir; Hans T. M. van Schie; et al. JAMA 303:144-149, 2010
Purpose of the study: To examine whether a PRP injection would improve outcome in chronic midportion Achilles tendinopathy.
The Study: A stratified, block-randomized, double-blind, placebocontrolled trial at a single center (The Hague Medical Center, Leidschendam, the Netherlands) of 54 randomized patients aged 18 to 70 years with chronic tendinopathy 2 to 7 cm above the Achilles tendon insertion. The trial was conducted between August 28, 2008, and January 29, 2009, with follow-up until July 16, 2009. Eccentric exercises (usual care) with either a PRP injection (PRP group) or saline injection (placebo group). Randomization was stratified by activity level.
Results: although both groups improved from baseline there was no difference statistically or clinically between the two groups. Reviewing the 95% confidence intervals about the primary outcome a clinically important difference was not missed.
Author’s conclusions: Among patients with chronic Achilles tendinopathy who were treated with eccentric exercises, a PRP injection compared with a saline injection did not result in greater improvement in pain and activity.
Study strengths:
Study weaknesses:
None
Comments:
A well-planned and reported clinical trial which should provide important information to practicing podiatrist utilizing platelet-rich plasma injections for foot pathology. The authors provide a clear description of the subjects and the intervention which allows for podiatric physicians to determine the relevancy to their practices.
1/2010